Xenon Pharmaceuticals (XENE) Reports Q3 Loss of $0.43
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.43), versus ($0.51) reported last year.
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham
- Amneal gets FDA approval for lanreotide injection, launches immediately
- Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Baird
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
